ASH: Reduced-Dose Anticoagulants Not Noninferior for Recurrent VTE
Noninferiority of reduced-dose anticoagulants could not be proven in patients with VTE who need extended anticoagulation
ASH: Auto-HCT Not Beneficial for Mantle Cell Lymphoma With Undetectable Residual Disease
Overall survival no better for those receiving autologous HCT plus maintenance rituximab versus rituximab alone
7.9 Percent of People of All Ages Uninsured in January to June 2024
No change seen in percentage of people who were uninsured from 2023 to first half of 2024; lower percentage had public coverage
Black Patients Have Similar Immune Checkpoint Inhibitor Effectiveness, Lower Toxicity
Black patients have longer time to treatment discontinuation, similar time to next treatment, slightly improved overall survival than White patients
PIVKA-II-Based Model IDs Liver Cancer Risk in Hep C-Related Cirrhosis
Model accurately predicts hepatocellular carcinoma among patients with HCV-related cirrhosis with SVR to DAAs
Fetal Aneuploid Tests Can Spot Occult Cancer in Pregnant Women
Findings seen in pregnant or postpartum women who receive unusual or nonreportable clinical cell-fee DNA-sequencing results
Centralized CRC Screening Outreach Intervention Improves Screening Rates
Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia
Overall Prevalence of Anemia 9.3 Percent in August 2021 to August 2023
Prevalence of anemia higher among females than males and in non-Hispanic Black females and males
Colorectal Cancer Risk Factors Important to Consider for Rescreening Interval
Findings seen for individuals with previous negative colonoscopy screening
2016 to 2021 Saw Drop in Cervical Cancer Mortality for Women Younger Than 25
Estimated 26 additional cervical cancer deaths would have been expected between 2016 and 2021 assuming trends continued
